Monte Rosa Therapeutics, Inc.

Ownership Transactions Reported by 34 Insiders

Symbol
GLUE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
321 Harrison Avenue, Suite 900, Boston, MA

Insiders trading volume in the past year

Monte Rosa Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bradley J. Bolzon PhD Director, 10%+ Owner $169M Jun 28, 2021
Edward T. Mathers 10%+ Owner $146M Jun 28, 2021
New Enterprise Associates 17, L.P. 10%+ Owner $146M Jun 28, 2021
Peter W. Sonsini 10%+ Owner $146M Jun 28, 2021
Anthony A. Florence Jr. 10%+ Owner $146M Jun 28, 2021
Scott D. Sandell 10%+ Owner $146M Jun 28, 2021
Rick Yang 10%+ Owner $146M Jun 28, 2021
Paul Edward Walker 10%+ Owner $146M Jun 28, 2021
Joshua Makower 10%+ Owner $146M Jun 28, 2021
Mohamad Makhzoumi 10%+ Owner $146M Jun 28, 2021
Forest Baskett 10%+ Owner $146M Jun 28, 2021
Liza Landsman 10%+ Owner $146M Jun 28, 2021
Carmen Chang 10%+ Owner $146M Jun 28, 2021
Cormorant Asset Management, LP Former 10% Owner $60.8M Jun 28, 2021
Versant Venture Capital VI, L.P. 10%+ Owner $53.2M -$12.3M -18.8% Oct 28, 2024
Markus Warmuth President & CEO, Director $5.12M Jan 2, 2025
Filip Janku Chief Medical Officer $425K Jan 2, 2025
Philip Nickson Chief Business & Legal Officer $339K Jan 2, 2025
Sharon Townson Chief Scientific Officer $339K Jan 2, 2025
Jennifer Champoux Chief Operating Officer $282K Jan 2, 2025
Edmund Dunn Principal Accounting Officer $243K -$11K -4.35% Jan 2, 2025
Owen B. Wallace Chief Scientific Officer $100K Jan 2, 2024
Chandra P. Leo Director $58.4K +$58.4K Mar 24, 2025
Kimberly Blackwell Director Jun 12, 2024
John C. Castle Chief Data Scientist Jan 3, 2023
Ajim Tamboli Chief Financial Officer Jan 3, 2023
Anthony M. Manning Director Jun 12, 2024
Jullian G. Jones Chief Business Officer Jan 2, 2024
Alexander Mayweg Director Jun 14, 2023
Jan Skvarka Director Jun 12, 2024
Ali Behbahani Director, 10%+ Owner Jun 12, 2024
Eric A. Hughes Director Dec 11, 2024
Andrew N. Schiff Director Jun 12, 2024
Christine Siu Director Jun 12, 2024

Recent Insider Transactions by Companies or Individuals for Monte Rosa Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.